Kalevi Pekka Richard Reijonen

FIT Biotech Oy engages in the business of researching, developing, and manufacturing diagnostic laboratory tests and pharmaceutical products. The firm is also involved in marketing gene transport unit vector technology to be used as a gene transport mechanism in gene therapeutic applications. The company was founded on May 17, 1995 and is headquartered in Tampere, Finland.

Medeia Therapeutics Oy operates a biotechnology company which discovers and develops new therapeutic approaches for diseases with unmet medical needs. It focuses areas which include the discovery, preclinical research and early development of novel therapeutics. The company’s research and development programs develops small molecules for life-threatening conditions of the elderly, focusing especially on serious neurological diseases such as Alzheimer’s disease, Parkinson’s disease, Amyotrophic lateral sclerosis and other degenerative diseases. Medeia Therapeutics was founded by Jari Eerik Koistinaho in 2006 and is headquartered in Kuopio, Finland.^ ^

Icosagen AS is a biotechnology company based in Tartu, Estonia. Established in 1999, the Estonian company offers contract research, development, and manufacturing services to biotechnology and pharmaceutical companies. With a team of over 190 experts, Icosagen specializes in discovering and producing recombinant proteins and antibodies. The private company comprises four entities, including Icosagen Cell Factory OÜ, Icosagen Technologies Inc., and Icopark OÜ. Icosagen provides antibody discovery and development services, food microbiology testing, and GMP-compliant high productivity CHO-based stable cell line development. The company collaborates with Future Style to offer its antigens and antibodies. Icosagen also supports functional activity testing of products in suitable cell-based activity assays.